Drug:
Reaction: MALAISE
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26940104 |
US |
60 | 2 |
Cardiac flutter, Fall, Concussion, Memory impairment, Malaise, COVID-19, Seizure, Drug ineffective, |
||||
UPADACITINIB, DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 2 | 26940185 |
US |
66 | 1 |
Syncope, Product availability issue, Malaise, Product use issue, |
||||
LACOSAMIDE, |
||||
| 3 | 26940248 |
US |
1 | |
Malaise, |
||||
DUPILUMAB, |
||||
| 4 | 26940327 |
US |
2 | |
Off label use, Vaginal discharge, B-lymphocyte count decreased, Malaise, Tension, |
||||
OCRELIZUMAB, |
||||
| 5 | 26940384 |
EU |
2 | |
Dysstasia, Nausea, Malaise, Dizziness, Off label use, |
||||
ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 6 | 26940468 |
US |
2 | |
Abdominal distension, Malaise, Pain in extremity, Weight increased, |
||||
ABALOPARATIDE, |
||||
| 7 | 26940514 |
US |
2 | |
Adverse drug reaction, Pharyngeal swelling, Weight decreased, Injection site pruritus, Injection site rash, Nausea, Hypersensitivity, Vomiting, Malaise, |
||||
ABALOPARATIDE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, |
||||
| 8 | 26940531 |
US |
2 | |
Wrist fracture, Abdominal discomfort, Abdominal pain upper, Injection site bruising, Malaise, Dizziness, Product dose omission in error, |
||||
ABALOPARATIDE, |
||||
| 9 | 26940540 |
US |
61 | 2 |
Abdominal discomfort, Decreased appetite, Unevaluable event, Viral infection, Malaise, Vomiting, Abdominal pain, |
||||
ABALOPARATIDE, EXTENDED PHENYTOIN SODIUM, GABAPENTIN, DIVALPROEX SODIUM, CENOBAMATE, |
||||
| 10 | 26940585 |
US |
||
Malaise, Therapy interrupted, Product availability issue, |
||||
THEOPHYLLINE ANHYDROUS, |
||||
| 11 | 26940652 |
US |
1 | |
Anxiety, Flushing, Malaise, Product administered at inappropriate site, Product communication issue, |
||||
EVOLOCUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ICOSAPENT ETHYL, ICOSAPENT ETHYL CAPSULES, ROSUVASTATIN, |
||||
| 12 | 26940654 |
US |
78 | 1 |
Chills, Diarrhoea, Malaise, Nausea, |
||||
LENALIDOMIDE, LENALIDOMIDE, |
||||
| 13 | 26940719 |
US |
2 | |
Emergency care, Weight increased, Sleep disorder, Fatigue, Abdominal distension, Heart rate increased, Feeling abnormal, Palpitations, Malaise, Lipids increased, Lipoprotein (a) increased, Anxiety, |
||||
ABALOPARATIDE, |
||||
| 14 | 26940908 |
CA |
58 | 2 |
Seizure, Haematochezia, Brain neoplasm, Sepsis, Malaise, Myalgia, Malaise, Pain in extremity, Diarrhoea, Nausea, Vomiting, Hyperhidrosis, Abdominal pain, Pyrexia, Memory impairment, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, METHOTREXATE, METHOTREXATE SODIUM, GABAPENTIN, FOLIC ACID, |
||||
| 15 | 26940913 |
US |
74 | 2 |
Joint stiffness, Gait disturbance, Unevaluable event, Neck pain, Nausea, Diarrhoea, Fatigue, Malaise, Heart rate increased, Headache, Blood calcium increased, Device use issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 16 | 26940982 |
US |
75 | 2 |
Depressed mood, Somnolence, Muscular weakness, Presyncope, Hypotension, Nervousness, Dizziness, Nausea, Back pain, Malaise, Headache, Asthenia, Fatigue, Feeling abnormal, |
||||
ABALOPARATIDE, LORAZEPAM, |
||||
| 17 | 26940986 |
US |
2 | |
Presyncope, Paraesthesia, Brain fog, Sensory disturbance, Injection site discomfort, Upper-airway cough syndrome, Respiratory tract infection, Nasopharyngitis, Vertigo, Dizziness, Muscle spasms, Nausea, Headache, Fatigue, Injection site pain, Injection site bruising, Constipation, Abdominal pain upper, Abdominal distension, Malaise, Pain in extremity, Diarrhoea, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ROSUVASTATIN, |
||||
| 18 | 26941011 |
US |
2 | |
Abdominal distension, Weight increased, Constipation, Malaise, Nausea, Vomiting, Diarrhoea, Dizziness, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 19 | 26941176 |
US |
2 | |
Lip dry, Intentional product misuse, Palpitations, Headache, Malaise, Pain in extremity, Nausea, Dizziness, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 20 | 26941261 |
US |
41 | 2 |
Loss of consciousness, Malaise, Dyskinesia, Intermenstrual bleeding, Somnambulism, Nausea, Somnolence, |
||||
SODIUM OXYBATE, MODAFINIL, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, |
||||
| 21 | 26941455 |
US |
55 | 2 |
Back pain, Arthralgia, Malaise, |
||||
ZOLEDRONIC ACID, AVAPRITINIB, |
||||
| 22 | 26941495 |
US |
2 | |
Nervousness, Balance disorder, Hyperhidrosis, Oral pain, Decreased appetite, Dizziness, Heart rate increased, Headache, Malaise, Fatigue, Palpitations, Bone pain, |
||||
ABALOPARATIDE, CALCIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FLUOXETINE HYDROCHLORIDE, |
||||
| 23 | 26941524 |
KH |
2 | |
Cholelithiasis, Chronic myeloid leukaemia, Malignant neoplasm progression, Vaginal haemorrhage, Uterine haemorrhage, Haematochezia, Hypothyroidism, Malaise, Diabetes mellitus, Loose tooth, Blood creatinine decreased, Varicose vein, Drug intolerance, Cardiac disorder, Crying, Transferrin saturation decreased, Blood cholesterol increased, Microalbuminuria, White blood cell count increased, Prothrombin time shortened, Blood lactate dehydrogenase abnormal, Lymphocyte count abnormal, Antinuclear antibody positive, Blood triglycerides increased, Product dose omission issue, Iron deficiency anaemia, Alanine aminotransferase abnormal, Aspartate aminotransferase abnormal, Manganese increased, Neutrophil count increased, Mean cell haemoglobin concentration abnormal, Neck pain, Back pain, Pallor, Ocular hyperaemia, Pain, Peripheral swelling, Oedema peripheral, Normochromic normocytic anaemia, Hepatomegaly, Dyslipidaemia, Hyperglycaemia, Hepatic steatosis, Arthralgia, Pain in extremity, Chest pain, Haemoglobin decreased, Anaemia, Dyspnoea, Anxiety, Tachycardia, White blood cell count abnormal, Cough, Blood pressure increased, Blood iron decreased, Cytogenetic analysis abnormal, Hypertension, Depression, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, NILOTINIB, DICLOFENAC, DICLOFENAC SODIUM, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, CALCIUM, |
||||
| 24 | 26941884 |
CA |
43 | 2 |
Breast cancer stage II, Asthenia, Dislocation of vertebra, Arthralgia, Gait inability, Malaise, Fluid retention, Rheumatoid factor positive, Urticaria, Joint swelling, Synovitis, Asthma, Hand deformity, Mobility decreased, Decreased appetite, Systemic lupus erythematosus, Wound, Rheumatoid arthritis, Lower limb fracture, Injury, Drug hypersensitivity, Road traffic accident, Musculoskeletal pain, Pemphigus, Blood cholesterol increased, Sciatica, Drug intolerance, Liver disorder, |
||||
ERENUMAB-AOOE, ERENUMAB-AOOE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, SECUKINUMAB, DICLOXACILLIN SODIUM, DICLOXACILLIN SODIUM, DICLOXACILLIN SODIUM, OXYCODONE, OXYCODONE, LEFLUNOMIDE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
| 25 | 26941892 |
US |
66 | 2 |
Blood pressure increased, Blood calcium increased, Palpitations, Headache, Malaise, Pain of skin, Bursitis, Flushing, Bone pain, Pain, Product dose omission in error, |
||||
ABALOPARATIDE, ABALOPARATIDE, HYDROCORTISONE, CALCIUM, |
||||
| 26 | 26941915 |
US |
2 | |
Gait disturbance, Balance disorder, Cardiac disorder, Muscular weakness, Illness, Blood calcium increased, Malaise, Nausea, Fatigue, Pain, |
||||
ABALOPARATIDE, ABALOPARATIDE, SODIUM POLYSTYRENE SULFONATE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, ACETAMINOPHEN, HEPARIN SODIUM, ERGOCALCIFEROL, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DANAZOL, FLUCONAZOLE, CHLOROQUINE PHOSPHATE, |
||||
| 27 | 26941931 |
CA |
40 | 2 |
Pneumonia, Migraine, Depression, Dyspepsia, Systemic lupus erythematosus, Hepatitis, Back injury, Blister, Vomiting, Peripheral venous disease, Hypertension, Malaise, Osteoarthritis, Joint swelling, Coeliac disease, Abdominal distension, Bursitis, Hypercholesterolaemia, Taste disorder, Hypersensitivity, Rheumatic fever, Arthropathy, Contusion, Fibromyalgia, Injury, Dry mouth, Rheumatoid arthritis, Gait inability, Infusion related reaction, Nail disorder, Arthralgia, Dyspnoea, Insomnia, Drug hypersensitivity, Synovitis, Gastrointestinal disorder, Stomatitis, Helicobacter infection, Neck pain, Psoriatic arthropathy, Hypoaesthesia, Sleep disorder, Injection site reaction, Irritable bowel syndrome, Onychomadesis, Duodenal ulcer perforation, Pericarditis, Nasopharyngitis, Hand deformity, Pemphigus, Alopecia, |
||||
ERENUMAB-AOOE, ETANERCEPT, ETANERCEPT, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, SECUKINUMAB, SECUKINUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, FOLIC ACID, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, MEPOLIZUMAB, TOFACITINIB, TOFACITINIB, AZATHIOPRINE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CANDESARTAN, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CORTISONE ACETATE, |
||||
| 28 | 26942021 |
US |
2 | |
Hypokalaemia, Hypomagnesaemia, Weight decreased, Abdominal discomfort, Malaise, Nausea, Tachycardia, |
||||
ABALOPARATIDE, |
||||
| 29 | 26942043 |
US |
1 | |
Hospitalisation, Malaise, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 30 | 26942074 |
EU |
74 | 2 |
Hypokinesia, Hallucination, On and off phenomenon, Movement disorder, Pain in extremity, Gait disturbance, Therapeutic product effect incomplete, Mobility decreased, Limb discomfort, Malaise, General physical health deterioration, Emotional disorder, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, PREGABALIN, QUETIAPINE, FOLIC ACID, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, BISOPROLOL FUMARATE, CANDESARTAN, RIVAROXABAN, |
||||
| 31 | 26942144 |
EU |
81 | 1 |
Malaise, Erythema, Hypertension, Dyspnoea, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, METHYLPREDNISOLONE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, LEUPROLIDE ACETATE, DAROLUTAMIDE, |
||||
| 32 | 26942269 |
US |
||
Off label use, Drug ineffective, Malaise, |
||||
OSIMERTINIB, |
||||
| 33 | 26942311 |
GB |
72 | 2 |
Brain fog, Abdominal pain upper, Malaise, Fatigue, |
||||
EZETIMIBE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, |
||||
| 34 | 26942388 |
BR |
48 | 2 |
Adverse drug reaction, Gastrointestinal tube insertion, Intestinal obstruction, Dyspepsia, Gastrooesophageal reflux disease, Malaise, Stress, |
||||
PANITUMUMAB, |
||||
| 35 | 26942402 |
US |
71 | |
Malaise, Device use error, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 36 | 26942409 |
EU |
64 | 1 |
Fall, Head injury, Malaise, Hyperkinesia, |
||||
FOSCARBIDOPA/FOSLEVODOPA, ROPINIROLE, CARBIDOPA AND LEVODOPA, |
||||
| 37 | 26942651 |
US |
2 | |
Vomiting, Malaise, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 38 | 26942679 |
US |
55 | 1 |
Malaise, Fatigue, Pain, |
||||
NATALIZUMAB, NATALIZUMAB, |
||||
| 39 | 26942915 |
57 | 1 | |
Muscle spasms, Muscular weakness, Neuralgia, Fatigue, Malaise, Pyrexia, Myalgia, Arthralgia, |
||||
MEROPENEM, APIXABAN, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, ERGOCALCIFEROL, |
||||
| 40 | 26943112 |
CA |
44 | 2 |
Breast cancer stage III, Folliculitis, Sciatica, Hypoaesthesia, Memory impairment, Dyspepsia, Taste disorder, Crohn^s disease, Bone erosion, Gait inability, Gastrooesophageal reflux disease, Pneumonia, Decreased appetite, Insomnia, Disability, Confusional state, Grip strength decreased, Sleep disorder due to a general medical condition, Product use in unapproved indication, Blister, Adjustment disorder with depressed mood, Dislocation of vertebra, Hypercholesterolaemia, Lip dry, Blepharospasm, Systemic lupus erythematosus, Therapeutic product effect decreased, Anxiety, Delirium, Impaired healing, Infusion site reaction, Malaise, Bursitis, Facet joint syndrome, Lower respiratory tract infection, Dyspnoea, Drug intolerance, Prescribed overdose, Helicobacter infection, Dizziness, Sleep disorder, Rash, Glossodynia, C-reactive protein increased, Ulcer haemorrhage, Incorrect route of product administration, Therapeutic product effect incomplete, Maternal exposure during pregnancy, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Respiratory disorder, Psoriatic arthropathy, Urticaria, Depression, Contusion, Hepatic cirrhosis, Product quality issue, Hypersensitivity, Blood cholesterol increased, Drug hypersensitivity, Sinusitis, Exostosis, Discomfort, Deep vein thrombosis postoperative, Intentional product use issue, Condition aggravated, Diarrhoea, Hand deformity, Gait disturbance, Lower limb fracture, X-ray abnormal, Pericarditis, Stomatitis, Back injury, Duodenal ulcer perforation, Lupus-like syndrome, Ear pain, Ill-defined disorder, Alopecia, Fatigue, Synovitis, Type 2 diabetes mellitus, Prescribed underdose, Exposure during pregnancy, Rheumatoid factor positive, Product use issue, Epilepsy, Rheumatoid arthritis, Gastrointestinal disorder, Swollen joint count increased, Red blood cell sedimentation rate increased, Treatment failure, Irritable bowel syndrome, Contraindicated product administered, Swelling, Hypertension, Breast cancer stage II, Laryngitis, Drug ineffective, Pyrexia, Asthenia, Headache, Medication error, General physical health deterioration, Asthma, Therapy non-responder, Hepatic enzyme increased, Chest pain, Rheumatic fever, Drug tolerance, Fibromyalgia, Dry mouth, Peripheral swelling, Infusion related reaction, |
||||
DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, INFLIXIMAB, ABATACEPT, OXYCODONE, OXYCODONE, CELECOXIB, CELECOXIB, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, PREDNISONE, PREDNISONE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, SARILUMAB, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, SECUKINUMAB, MEPOLIZUMAB, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CELECOXIB, CELECOXIB, RAMIPRIL, RAMIPRIL, LAMOTRIGINE, LAMOTRIGINE, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, PREDNISONE, PREDNISONE, |
||||
| 41 | 26943194 |
EU |
72 | 2 |
Faecaloma, Balance disorder, Brain fog, Malaise, Dizziness, Alopecia, Anaemia, Enteritis, Gastrointestinal inflammation, White blood cell count decreased, |
||||
FULVESTRANT, FULVESTRANT, ABEMACICLIB, |
||||
| 42 | 26943473 |
US |
2 | |
Sleep disorder due to a general medical condition, Extra dose administered, Nausea, Vomiting, Retching, Malaise, |
||||
TIRZEPATIDE, |
||||
| 43 | 26943530 |
US |
1 | |
Renal impairment, Malaise, Fatigue, Illness, |
||||
IPTACOPAN, |
||||
| 44 | 26943544 |
US |
1 | |
Feeling abnormal, Malaise, |
||||
RAVULIZUMAB, |
||||
| 45 | 26943566 |
US |
2 | |
Malaise, Nausea, |
||||
TIRZEPATIDE, |
||||
| 46 | 26943805 |
US |
||
Feeding disorder, Starvation, Skin laxity, Malaise, |
||||
TIRZEPATIDE, |
||||
| 47 | 26943982 |
US |
2 | |
Blood disorder, Malaise, Illness, Product dose omission issue, |
||||
BRENSOCATIB, ALBUTEROL SULFATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, BUDESONIDE, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, COLESEVELAM, DEXLANSOPRAZOLE, FAMOTIDINE, FISH OIL, MONTELUKAST, NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, SIMVASTATIN, TIOTROPIUM BROMIDE AND OLODATEROL, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, VITAMIN E, MONTELUKAST SODIUM, MAGNESIUM OXIDE, |
||||
| 48 | 26944023 |
CA |
74 | 2 |
Death, Pneumonia, Cardiac failure, Malaise, Peripheral swelling, Erythema, Arthralgia, Visual impairment, Gastroenteritis, |
||||
BENRALIZUMAB, BENRALIZUMAB, PREDNISONE, PREDNISONE, ALBUTEROL SULFATE, |
||||
| 49 | 26944034 |
CL |
62 | 2 |
Blood pressure increased, Feeling abnormal, Fall, Epilepsy, Anxiety, Ankle fracture, Migraine, Hypertension, Bradycardia, Hypotension, Amnesia, Blood creatinine increased, Diarrhoea, Nausea, Vomiting, Blood alkaline phosphatase increased, C-reactive protein abnormal, Blood urea abnormal, Blood cholesterol abnormal, Foot fracture, International normalised ratio abnormal, Blood potassium abnormal, Insomnia, Dizziness, White blood cell count decreased, Haematocrit decreased, Haemoglobin decreased, Depression, Skin discolouration, Malaise, Emotional distress, Headache, Abnormal behaviour, Ligament sprain, Myopia, Colitis, Contusion, Wound, Pain, Keratitis, Thrombosis, Metastases to bone, Loss of consciousness, Petit mal epilepsy, Choking, Asphyxia, Sarcoma, Metastases to lung, Neutrophil count decreased, Tinnitus, Immunodeficiency, Eye swelling, Pulmonary pain, Nasal ulcer, Noninfective gingivitis, Gingival erythema, Aphthous ulcer, Weight increased, Morton^s neuralgia, Hypoglycaemia, Food intolerance, Scab, Epistaxis, Nasal injury, Gait disturbance, Ageusia, Visual impairment, Musculoskeletal chest pain, General physical health deterioration, Influenza, Productive cough, Cough, Pharyngitis, Haemoptysis, Electric shock sensation, Full blood count decreased, Fat tissue increased, Fluid retention, Pain, Dry eye, Back pain, Fatigue, Dysgeusia, Abdominal discomfort, Diarrhoea, Headache, Depressed mood, Memory impairment, Weight decreased, Blood sodium increased, Aversion, Eye pain, Yawning, Eyelid margin crusting, Eye disorder, Swelling, Gastrointestinal disorder, Nervousness, Anisocytosis, Poikilocytosis, Polychromasia, Macrocytosis, Red cell distribution width increased, Elliptocytosis, Atrioventricular block first degree, Discomfort, Mean cell volume increased, Blood glucose increased, Rouleaux formation, Red blood cell sedimentation rate increased, Limb deformity, Oral herpes, Ill-defined disorder, Arthritis, Hypersensitivity, Pruritus, Pyrexia, Dry skin, Lymphocyte count decreased, Red blood cell count decreased, Decreased immune responsiveness, Thyroid mass, Visual impairment, Neoplasm, Gingival disorder, Pain in extremity, Vision blurred, Chills, Herpes virus infection, Agitation, Confusional state, Catheter site pain, Gastrooesophageal reflux disease, Oesophagitis, Stress, High density lipoprotein abnormal, Gait inability, Mobility decreased, Diplopia, Impaired healing, Viral diarrhoea, Nasopharyngitis, Alopecia, Tension headache, |
||||
ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, LETROZOLE, LETROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ANASTROZOLE, ANASTROZOLE TABLETS, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LANSOPRAZOLE, CALCIUM, MORPHINE, |
||||
| 50 | 26944041 |
US |
2 | |
Headache, Malaise, Abdominal discomfort, Dizziness, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 51 | 26944077 |
GB |
2 | |
Malaise, |
||||
VANZACAFTOR, TEZACAFTOR, AND DEUTIVACAFTOR, COLISTIMETHATE SODIUM, |
||||
| 52 | 26944080 |
GB |
2 | |
Malaise, |
||||
IVACAFTOR, |
||||
| 53 | 26944092 |
EU |
74 | 2 |
Syncope, Pyelonephritis, Suprapubic pain, Pyrexia, Pain, Chills, Bacteraemia, Alopecia, Anxiety, Diarrhoea, COVID-19, Pyrexia, Malaise, Limb discomfort, Decreased appetite, Dysgeusia, Lung opacity, Haemoglobin decreased, Red blood cell count decreased, Haematocrit decreased, Mean cell volume increased, Mean cell haemoglobin increased, White blood cell count decreased, Glomerular filtration rate decreased, Alanine aminotransferase decreased, Blood urea increased, Blood creatinine increased, Peripheral swelling, Pain in extremity, Bladder discomfort, Dysuria, Dizziness, Influenza, Hypotension, Depressed mood, Breast mass, Affect lability, Tearfulness, Bone scan abnormal, Asthenia, Pain in jaw, Decreased immune responsiveness, Laboratory test abnormal, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, |
||||
| 54 | 26944178 |
US |
39 | 2 |
Vomiting, Malaise, Nausea, Feeding disorder, Abdominal pain upper, Hypokinesia, Drug ineffective, |
||||
| 55 | 26944198 |
US |
32 | 2 |
Nausea, Burning sensation, Vomiting, Eructation, Abdominal pain upper, Malaise, |
||||
| 56 | 26944326 |
US |
2 | |
Drug ineffective, Abdominal discomfort, Malaise, Malaise, |
||||
| 57 | 26944327 |
US |
80 | 2 |
Abdominal pain upper, Malaise, Hypertension, Headache, |
||||
| 58 | 26944415 |
CA |
38 | |
Muscle spasms, Hypotension, Dizziness, Pain, Nausea, Oropharyngeal pain, Rhinorrhoea, Nasal congestion, Malaise, Decreased appetite, Abdominal discomfort, Frequent bowel movements, Nasopharyngitis, Abdominal pain, Fatigue, Pyrexia, Headache, Underdose, |
||||
INFLIXIMAB-DYYB, BUDESONIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
| 59 | 26944549 |
CA |
2 | |
Pneumonia, Malaise, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 60 | 26944851 |
EU |
1 | |
Malaise, Device issue, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 61 | 26944875 |
US |
2 | |
Arthritis, Bone pain, Malaise, Abdominal pain upper, Arthralgia, |
||||
ABALOPARATIDE, TERIPARATIDE, ACETYLCYSTEINE, POLYETHYLENE GLYCOL 3350, PSYLLIUM HUSK, BIOTIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, MELOXICAM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LANSOPRAZOLE, VIBEGRON, GABAPENTIN, CLONAZEPAM, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CICLOPIROX, BUPROPION, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, |
||||
| 62 | 26944891 |
US |
2 | |
Feeling abnormal, Fatigue, Arthralgia, Bone pain, Pain, Malaise, Abdominal pain upper, |
||||
ABALOPARATIDE, |
||||
| 63 | 26944927 |
JP |
6 | 1 |
Enterocolitis, Insomnia, Malaise, Taste disorder, Haematochezia, Pyrexia, Hepatic function abnormal, Abdominal pain upper, Erythema, Diarrhoea, |
||||
CABOZANTINIB, CABOZANTINIB, NIVOLUMAB, IPILIMUMAB, |
||||
| 64 | 26945055 |
US |
1 | |
Sluggishness, Malaise, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, |
||||
| 65 | 26945057 |
US |
2 | |
Nocturia, Feeling abnormal, Pain, Nausea, Headache, Malaise, |
||||
ABALOPARATIDE, |
||||
| 66 | 26945159 |
US |
2 | |
Mobility decreased, Malaise, |
||||
ABALOPARATIDE, |
||||
| 67 | 26945205 |
US |
70 | 2 |
Feeling jittery, Nausea, Malaise, Fatigue, |
||||
ABALOPARATIDE, |
||||
| 68 | 26945276 |
US |
2 | |
Gastrointestinal pain, Adverse event, Malaise, |
||||
ABALOPARATIDE, ABALOPARATIDE, METHIMAZOLE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, |
||||
| 69 | 26945284 |
US |
87 | 2 |
Myalgia, Feeling abnormal, Pain, Headache, Malaise, Nausea, Arthralgia, |
||||
ABALOPARATIDE, |
||||
| 70 | 26945363 |
EU |
53 | 1 |
Malaise, Nausea, Asthenia, Somnolence, Loss of consciousness, |
||||
OBINUTUZUMAB, |
||||
| 71 | 26945385 |
US |
82 | 2 |
Skin discolouration, Blood pressure increased, Dizziness, Headache, Malaise, |
||||
ABALOPARATIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, EPINEPHRINE, ADRENALINUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, LATANOPROST, MAGNESIUM, METHOCARBAMOL, METHOCARBAMOL TABLETS, TRIAMCINOLONE ACETONIDE, |
||||
| 72 | 26945496 |
US |
2 | |
Influenza like illness, Muscle spasms, Headache, Nausea, Injection site bruising, Malaise, Device defective, Liquid product physical issue, Liquid product physical issue, Off label use, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 73 | 26945517 |
67 | ||
Nausea, Vomiting, Malaise, |
||||
RUXOLITINIB, ALBUTEROL SULFATE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, TIZANIDINE, |
||||
| 74 | 26945542 |
US |
2 | |
Adverse drug reaction, Malaise, |
||||
ABALOPARATIDE, |
||||
| 75 | 26945549 |
US |
77 | 2 |
Somnolence, Illness, Bladder disorder, Malaise, Arthralgia, Pain, Intentional dose omission, |
||||
ABALOPARATIDE, VIBEGRON, MECLIZINE HYDROCHLORIDE, MECLIZINE, MECLIZINE HYDROCLORIDE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE ORAL, ACETAMINOPHEN, CHOLESTYRAMINE, LANSOPRAZOLE, BUPROPION, COLCHICINE, DESVENLAFAXINE SUCCINATE, |
||||
| 76 | 26945695 |
US |
60 | 2 |
Oxygen saturation decreased, Blood potassium increased, Malaise, Fatigue, |
||||
TOLVAPTAN, |
||||
| 77 | 26945712 |
CA |
62 | 2 |
Loss of personal independence in daily activities, Therapeutic product effect incomplete, Drug dependence, Dyspnoea, Lung adenocarcinoma stage IV, Steroid dependence, Chest discomfort, Malaise, Sleep disorder due to a general medical condition, Illness, Exercise tolerance decreased, Metastases to central nervous system, Pneumothorax, Wheezing, Chronic obstructive pulmonary disease, Bronchitis, Bone pain, Seizure, Heart rate increased, Asthma, Full blood count abnormal, Joint swelling, Gait disturbance, |
||||
PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, OXYGEN, 0XYGEN, OXYGEN, 0XYGEN, ERGOCALCIFEROL, ERGOCALCIFEROL, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, MEPOLIZUMAB, RISEDRONATE SODIUM, RISEDRONATE SODIUM, ALBUTEROL SULFATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ALBUTEROL SULFATE, ALBUTEROL, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, |
||||
| 78 | 26945783 |
US |
55 | 2 |
Hunger, Blood glucose decreased, Malaise, Dizziness, Fatigue, Injection site bruising, Product dose omission issue, Product delivery mechanism issue, Product use in unapproved indication, |
||||
ABALOPARATIDE, |
||||
| 79 | 26945825 |
SA |
72 | 2 |
Cerebrovascular accident, Asthma, Head titubation, Malaise, Drug ineffective, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 80 | 26945866 |
US |
75 | 1 |
Malaise, Dizziness, Blood pressure decreased, |
||||
SPARSENTAN, |
||||
| 81 | 26945906 |
BR |
2 | |
Arrhythmia, Malaise, Drug ineffective, Product quality issue, Cardiac disorder, Fatigue, Cardiac valve disease, |
||||
SACUBITRIL AND VALSARTAN, SACUBITRIL AND VALSARTAN, DAPAGLIFLOZIN, GABAPENTIN, SERTRALINE, |
||||
| 82 | 26945924 |
US |
2 | |
Hospitalisation, Adverse event, Malaise, |
||||
ABALOPARATIDE, ABALOPARATIDE, CLONIDINE, |
||||
| 83 | 26945947 |
US |
54 | 2 |
Illness, Dizziness, Malaise, Fatigue, Vertigo, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 84 | 26945962 |
US |
2 | |
Viral infection, Injection site induration, Malaise, Muscle spasms, Injection site bruising, Injection site erythema, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 85 | 26945965 |
US |
2 | |
Blood iron increased, Hypertension, Muscle spasms, Orthostatic hypotension, Back pain, Malaise, Urticaria, Abdominal discomfort, Nausea, Fatigue, Pruritus, Circumstance or information capable of leading to medication error, Needle issue, Drug ineffective, Product dose omission issue, Inappropriate schedule of product administration, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, CEFDINIR, PREDNISONE, CALCIUM, |
||||
| 86 | 26946007 |
US |
2 | |
Blood calcium decreased, Headache, Arthralgia, Nausea, Vertigo, Blood calcium increased, Malaise, Drug ineffective, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 87 | 26946100 |
US |
2 | |
Muscle discomfort, Myalgia, Arthralgia, Nausea, Malaise, Pain, Bone pain, Off label use, |
||||
ABALOPARATIDE, |
||||
| 88 | 26946226 |
US |
66 | 2 |
Malaise, Alopecia, Blood calcium decreased, Hypotension, |
||||
SPARSENTAN, SPARSENTAN, AMLODIPINE, |
||||
| 89 | 26946266 |
US |
2 | |
Adverse reaction, Hypersomnia, Vitamin B12 decreased, Unevaluable event, Dizziness, Malaise, |
||||
ABALOPARATIDE, |
||||
| 90 | 26946269 |
US |
2 | |
Facial pain, Gastrooesophageal reflux disease, Neck pain, Pain in jaw, Nasopharyngitis, Illness, Chills, Adverse drug reaction, Nausea, Malaise, Pain in extremity, Diarrhoea, Constipation, |
||||
ABALOPARATIDE, ABALOPARATIDE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, PSYLLIUM HUSK, CYANOCOBALAMIN, GABAPENTIN, POLYETHYLENE GLYCOL 3350, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, BIMATOPROST, CELECOXIB, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, |
||||
| 91 | 26946285 |
US |
2 | |
Emergency care, Mobility decreased, Malaise, |
||||
ABALOPARATIDE, |
||||
| 92 | 26946321 |
CA |
40 | 2 |
Back injury, Fall, Arthralgia, Liver function test increased, Muscle spasms, Bursitis, Dyspepsia, Nail disorder, Vomiting, Mobility decreased, Osteoarthritis, C-reactive protein increased, Confusional state, Blood cholesterol increased, Injury, Swelling, Drug hypersensitivity, Diarrhoea, Dyspnoea, Abdominal discomfort, Grip strength decreased, Hand deformity, Headache, Arthropathy, Abdominal distension, Malaise, Folliculitis, Onychomadesis, Memory impairment, Hypertension, Gastrooesophageal reflux disease, Hypersensitivity, Normal newborn, Nausea, Onychomycosis, Peripheral swelling, Glossodynia, Maternal exposure timing unspecified, Maternal exposure during pregnancy, Exposure during pregnancy, Product label confusion, |
||||
ETANERCEPT, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ERENUMAB-AOOE, DICLOFENAC, DICLOFENAC SODIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ATOMOXETINE HYDROCHLORIDE, AZATHIOPRINE, CAFFEINE, CAFFEINE, CAFFEINE, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CANDESARTAN, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, |
||||
| 93 | 26946323 |
US |
||
Malaise, |
||||
OCRELIZUMAB, |
||||
| 94 | 26946357 |
US |
2 | |
Illness, Tremor, Balance disorder, Fall, Dehydration, Weight decreased, Bowel movement irregularity, Diarrhoea, Vomiting, Asthenia, Malaise, |
||||
ABALOPARATIDE, |
||||
| 95 | 26946366 |
US |
61 | 2 |
Abdominal tenderness, Depression, Influenza like illness, Abdominal distension, Contusion, Nausea, Dizziness, Malaise, Palpitations, Arthralgia, Fatigue, |
||||
ABALOPARATIDE, |
||||
| 96 | 26946384 |
US |
2 | |
Flushing, Hyperhidrosis, Irritable bowel syndrome, Decreased appetite, Nausea, Headache, Injection site pain, Fatigue, Asthenia, Malaise, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, DIPHENHYDRAMINE HYDROCHLORIDE, ERGOCALCIFEROL, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, TIRZEPATIDE, |
||||
| 97 | 26946437 |
70 | 2 | |
Addison^s disease, Haematochezia, Inappropriate schedule of product administration, Intentional dose omission, Intentional product use issue, Malaise, Nausea, Pain, Therapeutic response shortened, Weight increased, |
||||
TRAMADOL HYDROCHLORIDE, INFLIXIMAB, |
||||
| 98 | 26946457 |
US |
2 | |
Fear of injection, Poor quality sleep, Abdominal discomfort, Nausea, Fatigue, Muscle spasms, Abdominal pain upper, Headache, Malaise, Device use error, Liquid product physical issue, Device issue, Off label use, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, CYANOCOBALAMIN, ERGOCALCIFEROL, PROGESTERONE, |
||||
| 99 | 26946563 |
US |
2 | |
Somnolence, Fatigue, Palpitations, Heart rate increased, Malaise, Pain, |
||||
ABALOPARATIDE, |
||||
| 100 | 26946567 |
US |
57 | 1 |
Abdominal pain upper, Nausea, Frequent bowel movements, Malaise, Generalised oedema, Arthralgia, Pain in extremity, |
||||
SPARSENTAN, SPARSENTAN, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30